ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,585.09
      -0.52%
      US Tech 100
      18,902.00
      -0.04%
      Dow Jones
      41,488.69
      -1.01%
      Brent Oil
      69.34
      0.43%
      Bitcoin
      82,302.27
      4.88%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. PharmaCyte Biotech Inc (PMCB) Quote

      PharmaCyte Biotech Inc

      PharmaCyte Biotech Inc (PMCB)

      NASDAQ
      1.68
      -0.10
      ( -5.62% )
      Updated: 13:57:31
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.68
      Bid
      1.68
      Ask
      1.78
      Volume
      3,130
      1.67 Day's Range 1.79
      1.39 52 Week Range 2.58
      Market Cap
      11.706M
      Previous Close
      1.78
      Open
      1.79
      Last Trade
      1
      @
      1.78
      Last Trade Time
      13:59:48
      Financial Volume
      $ 5,317
      VWAP
      1.6986
      Average Volume (3m)
      18,280
      Shares Outstanding
      6,968,134
      Dividend Yield
      -
      PE Ratio
      -0.69
      Earnings Per Share (EPS)
      -2.47
      Revenue
      -
      Net Profit
      -17.24M

      About PharmaCyte Biotech Inc

      PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technol... PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Medicinal Chems,botanicl Pds
      Website
      ir.pharmacyte.com
      Headquarters
      Reno, Nevada, USA
      Founded
      2018
      PharmaCyte Biotech Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PMCB. The last closing price for PharmaCyte Biotech was $1.78. Over the last year, PharmaCyte Biotech shares have traded in a share price range of $ 1.39 to $ 2.58.

      PharmaCyte Biotech currently has 6,968,134 shares outstanding. The market capitalization of PharmaCyte Biotech is $12.40 million. PharmaCyte Biotech has a price to earnings ratio (PE ratio) of -0.69.

      Ask ADVFN Intelligence (AI)

      PMCB Latest News

      More News

      Form ARS - Annual Report to Security Holders
      Edgar (US Regulatory)
      22 hours ago
      PMCB (-5.62%)

      Form DEF 14A - Other definitive proxy statements
      Edgar (US Regulatory)
      22 hours ago
      PMCB (-5.62%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 26 2025
      PMCB (-5.62%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      December 13 2024
      PMCB (-5.62%)

      Form S-8 - Securities to be offered to employees in employee benefit plans
      Edgar (US Regulatory)
      December 04 2024
      PMCB (-5.62%)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
      Edgar (US Regulatory)
      November 13 2024
      PMCB (-5.62%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.04042.464015613561.63961.81991.6284971.77282217CS
      40.1711.25827814571.511.91.4635282361.71644272CS
      120.010.598802395211.671.91.45182801.66059882CS
      26-0.03-1.754385964911.712.42291.45265731.77025637CS
      52-0.37-18.04878048782.052.581.39242781.94650669CS
      156-0.47-21.86046511632.153.231.39858272.34036241CS
      260-1.4-45.45454545453.089.981.395957206.01353899CS

      PMCB - Frequently Asked Questions (FAQ)

      What is the current PharmaCyte Biotech share price?
      The current share price of PharmaCyte Biotech is $ 1.68
      How many PharmaCyte Biotech shares are in issue?
      PharmaCyte Biotech has 6,968,134 shares in issue
      What is the market cap of PharmaCyte Biotech?
      The market capitalisation of PharmaCyte Biotech is USD 12.4M
      What is the 1 year trading range for PharmaCyte Biotech share price?
      PharmaCyte Biotech has traded in the range of $ 1.39 to $ 2.58 during the past year
      What is the PE ratio of PharmaCyte Biotech?
      The price to earnings ratio of PharmaCyte Biotech is -0.69
      What is the reporting currency for PharmaCyte Biotech?
      PharmaCyte Biotech reports financial results in USD
      What is the latest annual profit for PharmaCyte Biotech?
      The latest annual profit of PharmaCyte Biotech is USD -17.24M
      What is the registered address of PharmaCyte Biotech?
      The registered address for PharmaCyte Biotech is 401 RYLAND ST STE 200-A, RENO, NEVADA, 89502
      What is the PharmaCyte Biotech website address?
      The website address for PharmaCyte Biotech is ir.pharmacyte.com
      Which industry sector does PharmaCyte Biotech operate in?
      PharmaCyte Biotech operates in the MEDICINAL CHEMS,BOTANICL PDS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RAYRaytech Holding Ltd
      $ 2.07
      (137.93%)
      		86.41M
      TSVT2seventy bio Inc
      $ 4.945
      (76.61%)
      		29.38M
      SYRSSyros Pharmaceuticals Inc
      $ 0.154899
      (69.10%)
      		649.62M
      TNONTenon Medical Inc
      $ 1.7793
      (42.34%)
      		31.3M
      HSAIHesai Group
      $ 22.37
      (39.73%)
      		21.84M
      WCTWellchange Holdings Company Limited
      $ 0.6683
      (-73.37%)
      		26.31M
      ARVNArvinas Inc
      $ 8.46
      (-51.82%)
      		12.94M
      LZMHLZ Technology Holdings Ltd
      $ 9.58
      (-38.83%)
      		474.79k
      SPGCSacks Parente Golf Inc
      $ 0.1059
      (-33.85%)
      		29.25M
      ARBBARB IOT Group Ltd
      $ 0.7125
      (-28.75%)
      		2.02M
      SYRSSyros Pharmaceuticals Inc
      $ 0.154899
      (69.10%)
      		649.62M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0404
      (20.60%)
      		381.11M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 7.775
      (5.35%)
      		240.8M
      NVDANVIDIA Corporation
      $ 109.03
      (1.92%)
      		236.05M
      CUTRCutera Inc
      $ 0.1125
      (-12.45%)
      		208.71M

      PMCB Discussion

      View Posts
      joe_techi joe_techi 2 weeks ago
      Too sleazy for Marcum lol.
      👍️0
      hockeypond hockeypond 1 month ago
      It's been a long time and hope all is well....you must live in SD or southern CA being a Charger fan....I also am a fan, a frustrated fan, but they will get much better. BTW, keep ECGS on your radar they are moving and I've seen this twice before when it touched .02 and each time the run is .50+ and this time I think it will be better. They bought one of the leading bottle water companies in Hawaii last year and are expanding operations....low float 5m and 40m shares out....
      👍️0
      Edward Edward 2 months ago
      longboarder7892

      13 minutes ago 1/23/2025.


      Hi I thought you might be interested to know that Ken Wagonner from PMCB is the CEO of AVAI - sad to see him still allowed to be a CEO

      No he is not! Chris Winter is the CEO ( see page 36 and the date of 1/25/2025 and page 37):


      https://ir.avanttechnologies.com/all-sec-filings
      No he is not (Chris Winter is ( page 39 and the date 1/21/2025
      👍️0
      Monksdream Monksdream 3 months ago
      PMCB, under $2
      👍️0
      $Pistol Pete$ $Pistol Pete$ 3 months ago
      Scam company and zero product
      👍️0
      mick mick 4 months ago
      what have you been trading ????? cybl interesting
      👍️0
      mick mick 4 months ago
      thank for peter.
      👍️0
      $Pistol Pete$ $Pistol Pete$ 4 months ago
      All good my Friend
      👍️0
      mick mick 5 months ago
      HOW IS YOUR PROPERTIES DOING PETER ????? GLAD TO HEAR FROM YOU.
      👍️0
      $Pistol Pete$ $Pistol Pete$ 5 months ago
      Thanks Mick
      👍️0
      mick mick 5 months ago
      i see you busy here peter. you are a friend peter \\//
      👍️0
      $Pistol Pete$ $Pistol Pete$ 6 months ago
      This scam will get below $1 by end of this year
      👍️0
      Monksdream Monksdream 7 months ago
      PMCB new 52 week low
      👍️0
      $Pistol Pete$ $Pistol Pete$ 8 months ago
      Still a scam
      👍️0
      $Pistol Pete$ $Pistol Pete$ 9 months ago
      Just dump this one for a quick profit
      👍️0
      $Pistol Pete$ $Pistol Pete$ 10 months ago
      Agreed
      👍️0
      Fred_Lab Fred_Lab 11 months ago
      It seems pretty obvious and unfortunate that whatever resources PMCB has will just be used to support "management" until the money is gone and then they will be gone also. If their technology had any value at all we investors and potential patients would have known something by now. Very sad but true... wishing it were not.
      👍️0
      $Pistol Pete$ $Pistol Pete$ 12 months ago
      Is this scam still alive?
      👍️0
      longboarder7892 longboarder7892 1 year ago
      it should like my p+l is showing huge gains in FEMY. We took in a huge amount of shares under 1.00 and PMCB own close to 13 million shares of FEMY. Looks like all my losses from PMCB are covered already from the move in FEMY. ?So sorry to see PMCB wont be trying to use the product in the cure for PC. For those that hate the old CEO of PMCB karma has come back to him. He is not in good health. whatever goes around comes around. If this helps anyone---
      PharmaCyte Biotech Inc. 10% Owner 0f FEMY 12,711,864 shares= as of now thats over a 12 million plus profit

      Hey have a great day
      👍️0
      longboarder7892 longboarder7892 1 year ago
      it should like my p+l is showing huge gains in FEMY. We took in a huge amount of shares under 1.00 and PMCB own close to 13 million shares of FEMY. Looks like all my losses from PMCB are covered already from the move in FEMY. ?So sorry to see PMCB wont be trying to use the product in the cure for PC. For those that hate the old CEO of PMCB karma has come back to him. He is not in good health. whatever goes around comes around. If this helps anyone---
      PharmaCyte Biotech Inc. 10% Owner 0f FEMY 12,711,864 shares= as of now thats over a 12 million plus profit

      Hey have a great day
      👍️0
      wuniv4ever wuniv4ever 1 year ago
      If PMCB bought $5million in (FEMY) and that stock has almost tripled since they did should the charts show something a little different?
      👍️0
      $Pistol Pete$ $Pistol Pete$ 1 year ago
      Scam…..buyers be aware
      👍️0
      Edward Edward 1 year ago
      ????? Why would i care.

      I haven't owned this stock for many years.

      I have no interest in PMCB.
      👍️0
      Edward Edward 1 year ago
      ??????????

      Why would i care.

      I haven't owned this stock for many years.

      I have no interest in PMCB.
      👍️0
      $Pistol Pete$ $Pistol Pete$ 1 year ago
      This company is dead
      👍️0
      $Pistol Pete$ $Pistol Pete$ 1 year ago
      Are you still holding this scam?
      👍️0
      Edward Edward 1 year ago
      A 52 week low today.

      Expected since they have no product and an unscrupulous;management.
      👍️0
      $Pistol Pete$ $Pistol Pete$ 1 year ago
      Paint job
      👍️0
      spiritthing spiritthing 1 year ago
      Quote up over 20% after hours +++What is happening?
      👍️0
      $Pistol Pete$ $Pistol Pete$ 1 year ago
      $2 is coming
      👍️0
      Edward Edward 1 year ago
      Too funny-- Iroquois say in the s-3/a filing:

      "Any proceeds we receive from the exercise of the Warrants will be used for general corporate purpose."

      General corporate purposes??? What corporate purposes do they have, there are no operations.

      Translation more money to pay themselves and their investment funds holdings to make more money.

      They make the former CEO KW look like an angel, and he was a fake, misleading shareholders.
      👍️0
      joe_techi joe_techi 1 year ago
      Risks Associated with Our Business. Our business and our ability to implement our business strategy are subject to numerous risks, mainly in that we don't do anything. If the market recognizes that doing nothing has no value it may negatively impact our share price
      👍️0
      Edward Edward 1 year ago
      NO KIDDING!!!!!!

      THAT'S WHY I DO NO NOT OWN ANY SHARES OF PMCB OR HAVE ANY INTENTION TO BUY ANY!!
      👍️0
      $Pistol Pete$ $Pistol Pete$ 1 year ago
      They has zero product and just a shell to sale shares to uneducated people
      👍️0
      longboarder7892 longboarder7892 1 year ago
      The CFO is so busy lol he couldnt file on time-Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
      👍️0
      joe_techi joe_techi 1 year ago
      So much going on with the biz that....Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
      👍️0
      joe_techi joe_techi 2 years ago
      They have authorized more new shares to sell to suckers so they can pay themselves for doing nothing. That is their corporate mission statement
      👍️ 1
      Edward Edward 2 years ago
      What exactly is management doing at PMCB besides drawing money for fees as directors and as board members-- Answer is nothing.

      They can't sell the company since PMCB has an unsaleable product that won't get accepted by the FDA. Any patents or rights are not worth anything since there is no product.

      Current Board and Directors are set for a long time getting paid because of the cash .

      Take the cash away and the assets are minuscule.
      👍️0
      $Pistol Pete$ $Pistol Pete$ 2 years ago
      Is this scam still alive? I thought it should be delisted by now
      👍️0
      $Pistol Pete$ $Pistol Pete$ 2 years ago
      But now it is still a scam. What take over? Nothing to take over except selling shares and dump into uneducated investors on this scam company
      👍️0
      longboarder7892 longboarder7892 2 years ago
      looks like the takeover will be happen soon. 8-10 dollars would be fine
      👍️0
      Edward Edward 2 years ago
      ????????????

      I haven't owned this for years!!!!!!!!!
      👍️0
      $Pistol Pete$ $Pistol Pete$ 2 years ago
      $PMCB 100% SELL

      https://www.barchart.com/stocks/quotes/PMCB/opinion

      Dump and run away from this scam
      👍️0
      $Pistol Pete$ $Pistol Pete$ 2 years ago
      Is this scam still alive? How is the trade for $2.83?
      👍️0
      $Pistol Pete$ $Pistol Pete$ 2 years ago
      Karma to KW. He should be in jail
      👍️0
      saladan2 saladan2 2 years ago
      They sure are crooks.
      👍️0
      tjclark0551 tjclark0551 2 years ago
      Hey Diana,

      Thanks for the response. All I can say is Holly Smoke Screen Bat Man they're only pushing hot air. Unbelievable!!!
      👍️0
      Edward Edward 2 years ago
      Yep.

      At least KW's Scam was using Pancreatic cancer. Iroquois Scam is for a company that was shut down and doesn't have any operations.And they still increase the authorized shares. LOL.
      👍️0
      $Pistol Pete$ $Pistol Pete$ 2 years ago
      All I can say is “SCAM”
      👍️0
      Edward Edward 2 years ago
      Comical isn't it.

      It's for:

      the underlying shares of convertible preferred stock and warrants issued by us pursuant to the terms of that certain Securities Purchase Agreement, dated May 9, 2023, by and among PharmaCyte Biotech, Inc. and the investors named therein, in an amount equal to or in excess of 20% of our common stock outstanding before the issuance of such convertible preferred stock and warrants (including any amortization payments made to the holders of convertible preferred stock in the form of issuance of shares of common stock and upon the operation of?anti-dilution provisions contained in such convertible preferred stock and warrants);

      https://www.otcmarkets.com/filing/html?id=16722179&guid=1ID-kaPm862pJth


      FIRST THEY REDUCE THE OUTSTANDING AND THE ISSUE CONVERTIBLE PREFERRED SHARES AND WARRANTS! TOO FUNNY!
      👍️0

      Your Recent History

      NASDAQ
      PMCB
      PharmaCyte Biotech
      NASDAQ
      ACGN
      Aceragen
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads